Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Dalamaga

Showing results (1-10 of 261) with videos related to

Pageof 27
Sort By:
World Journal of Experimental Medicine|February 13, 2014
Interplay of adipokines and myokines in cancer pathophysiology: Emerging therapeutic implicationsMaria Dalamaga
World Journal of Experimental Medicine|February 13, 2014
Obesity, insulin resistance, adipocytokines and breast cancer: New biomarkers and attractive therapeutic targetsMaria Dalamaga
Metabolism Open|April 20, 2026
Bridging exercise biology and immunometabolism: A novel irisin pathway toward next-generation metabolic and neurodegenerative therapiesMaria Dalamaga
Metabolism Open|April 20, 2026
Adipogenin-seipin, lipid droplet architecture and the expanding metabolic frontier: Implications for metabolic disorders and cancerMaria Dalamaga
Biomarkers in Medicine|December 12, 2013
Resistin as a biomarker linking obesity and inflammation to cancer: potential clinical perspectivesMaria Dalamaga
Medical Hypotheses|August 28, 2012
Nicotinamide phosphoribosyl-transferase/visfatin: a missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challengesMaria Dalamaga
Metabolism Open|July 16, 2024
Clinical metabolomics: Useful insights, perspectives and challengesMaria Dalamaga
Metabolism Open|June 22, 2026
What's in a name? From PCOS to polyendocrine metabolic ovarian syndrome: A metabolic reframing, promise, controversies, and challenges aheadMaria Dalamaga
Metabolism Open|January 7, 2025
Targeting cardiolipin metabolism for Parkinson's disease therapyJunli Liu, Maria Dalamaga
Metabolism Open|May 24, 2021
Serum bilirubin to fetuin-A ratio as a prognostic biomarker in critically ill patients with sepsisIrene Karampela, Maria Dalamaga
Pageof 27

Showing results (1-10 of 261) with videos related to

Sort By:
Pageof 27
World Journal of Experimental Medicine|February 13, 2014
Interplay of adipokines and myokines in cancer pathophysiology: Emerging therapeutic implicationsMaria Dalamaga
World Journal of Experimental Medicine|February 13, 2014
Obesity, insulin resistance, adipocytokines and breast cancer: New biomarkers and attractive therapeutic targetsMaria Dalamaga
Metabolism Open|April 20, 2026
Bridging exercise biology and immunometabolism: A novel irisin pathway toward next-generation metabolic and neurodegenerative therapiesMaria Dalamaga
Metabolism Open|April 20, 2026
Adipogenin-seipin, lipid droplet architecture and the expanding metabolic frontier: Implications for metabolic disorders and cancerMaria Dalamaga
Biomarkers in Medicine|December 12, 2013
Resistin as a biomarker linking obesity and inflammation to cancer: potential clinical perspectivesMaria Dalamaga
Medical Hypotheses|August 28, 2012
Nicotinamide phosphoribosyl-transferase/visfatin: a missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challengesMaria Dalamaga
Metabolism Open|July 16, 2024
Clinical metabolomics: Useful insights, perspectives and challengesMaria Dalamaga
Metabolism Open|June 22, 2026
What's in a name? From PCOS to polyendocrine metabolic ovarian syndrome: A metabolic reframing, promise, controversies, and challenges aheadMaria Dalamaga
Metabolism Open|January 7, 2025
Targeting cardiolipin metabolism for Parkinson's disease therapyJunli Liu, Maria Dalamaga
Metabolism Open|May 24, 2021
Serum bilirubin to fetuin-A ratio as a prognostic biomarker in critically ill patients with sepsisIrene Karampela, Maria Dalamaga
Pageof 27